Treatment of Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplant Recipients: Effect of Rituximab

Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation is a complication that often leads to graft loss. There is no consensus on the optimal treatment of recurrent FSGS. Rituximab, a monoclonal antibody to CD20, may be a useful treatment of this complication. Methods. W...

詳細記述

保存先:
書誌詳細
主要な著者: Sethna, Christine, Benchimol, Corinne, Hotchkiss, Hilary, Frank, Rachel, Infante, Lulette, Vento, Suzanne, Trachtman, Howard
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2011
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090748/
https://ncbi.nlm.nih.gov/pubmed/21577271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/389542
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料